Rankings
▼
Calendar
EWTX Q4 2025 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
EWTX
Edgewise Therapeutics, Inc.
$3B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$56M
Net Income
-$50M
EPS (Diluted)
$-0.47
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$38M
Stock-Based Comp.
-$25M
Balance Sheet
Total Assets
$553M
Total Liabilities
$30M
Stockholders' Equity
$522M
Cash & Equivalents
$61M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$56M
-$46M
-22.9%
Net Income
-$50M
-$40M
-26.6%
← FY 2025
All Quarters